These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1517500)

  • 1. Generalized nodular cutaneous pseudolymphoma associated with phenytoin therapy. Use of T-cell receptor gene rearrangement in diagnosis and clinical review of cutaneous reactions to phenytoin.
    Braddock SW; Harrington D; Vose J
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 2):337-40. PubMed ID: 1517500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin-induced pseudolymphoma. A report of a case and review of the literature.
    Harris DW; Ostlere L; Buckley C; Whittaker S; Sweny P; Rustin MH
    Br J Dermatol; 1992 Oct; 127(4):403-6. PubMed ID: 1419762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas.
    Bakels V; van Oostveen JW; van der Putte SC; Meijer CJ; Willemze R
    Am J Pathol; 1997 Jun; 150(6):1941-9. PubMed ID: 9176388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell receptor gene rearrangement analysis in the early diagnosis of cutaneous T-cell lymphoma.
    Zelickson BD; Peters MS; Pittelkow MR
    Dermatol Clin; 1994 Apr; 12(2):335-40. PubMed ID: 8045045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodiagnosis in cutaneous T cell lymphoma: how does gene expression of the variable region of the T cell receptor fit into the diagnostic and pathophysiological picture of T cell neoplasia.
    Fivenson DP; Nickoloff BJ
    J Cutan Pathol; 1992 Feb; 19(1):1-5. PubMed ID: 1556262
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome.
    D'Incan M; Souteyrand P; Bignon YJ; Fonck Y; Roger H
    Arch Dermatol; 1992 Oct; 128(10):1371-4. PubMed ID: 1417026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous T-cell lymphoma-like drug eruption in an HIV-positive patient taking vancomycin and rifampin.
    Macisaac JL; Ward CE; Pratt M
    J Cutan Med Surg; 2013; 17(6):433-6. PubMed ID: 24138984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and classification of cutaneous pseudolymphoma. Historical review and perspectives].
    Rijlaarsdam JU; Willemze R
    Ann Dermatol Venereol; 1993; 120(1):100-6. PubMed ID: 8338321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic criteria for early diagnosis of cutaneous T-cell lymphoma.
    Smith NP
    Dermatol Clin; 1994 Apr; 12(2):315-22. PubMed ID: 8045042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of molecular analysis in the diagnosis of cutaneous lymphoid infiltrates.
    Flaig MJ; Schuhmann K; Sander CA
    Semin Cutan Med Surg; 2000 Jun; 19(2):87-90. PubMed ID: 10892709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders.
    Greisser J; Palmedo G; Sander C; Kutzner H; Kazakov DV; Roos M; Burg G; Kempf W
    J Cutan Pathol; 2006 Nov; 33(11):711-5. PubMed ID: 17083688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of clonal T-cell receptor gamma gene rearrangement with the use of PCR-DGGE for diagnosis of erythroderma].
    Cordel N; Lenormand B; Courville P; Lauret P; Joly P
    Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 1):220-3. PubMed ID: 11319384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
    Magro CM; Momtahen S
    Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
    Lan TT; Brown NA; Hristov AC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
    Bergman R
    Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: report of a case with spontaneous resolution].
    Messeguer F; Gimeno E; Agusti-Mejias A; San Juan J
    Actas Dermosifiliogr; 2011 Oct; 102(8):636-8. PubMed ID: 21605848
    [No Abstract]   [Full Text] [Related]  

  • 18. Composite cutaneous lymphoma in a patient with rheumatoid arthritis treated with methotrexate.
    Huwait H; Wang B; Shustik C; Michel RP
    Am J Dermatopathol; 2010 Feb; 32(1):65-70. PubMed ID: 20098085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of molecular analysis by PCR in the diagnosis of cutaneous lymphocytic infiltrates.
    Holm N; Flaig MJ; Yazdi AS; Sander CA
    J Cutan Pathol; 2002 Sep; 29(8):447-52. PubMed ID: 12207737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic signs of cutaneous lymphomas.
    Burg G; Kempf W; Dummer R
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):358-60. PubMed ID: 11730054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.